NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
3.470
-0.090 (-2.53%)
Jun 3, 2026, 4:00 PM EDT - Market closed
NMTC Revenue
NeuroOne Medical Technologies had revenue of $2.39M in the quarter ending March 31, 2026, with 72.46% growth. This brings the company's revenue in the last twelve months to $9.72M, up 10.98% year-over-year. In the fiscal year ending September 30, 2025, NeuroOne Medical Technologies had annual revenue of $12.10M with 250.35% growth.
Revenue (ttm)
$9.72M
Revenue Growth
+10.98%
P/S Ratio
2.35
Revenue / Employee
$706,711
Employees
18
Market Cap
29.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 12.10M | 8.64M | 250.35% |
| Sep 30, 2024 | 3.45M | 45.37K | 1.33% |
| Sep 30, 2023 | 3.41M | 1.29M | 60.73% |
| Sep 30, 2022 | 2.12M | 1.88M | 772.60% |
| Sep 30, 2021 | 242.96K | -1.68M | -87.39% |
| Sep 30, 2020 | 1.93M | - | - |
| Sep 30, 2019 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | 773.00 | -476.00 | -38.11% |
| Dec 31, 2013 | 1.25K | 328.00 | 35.61% |
| Dec 31, 2012 | 921.00 | -4.48K | -82.94% |
| Dec 31, 2011 | 5.40K | 4.23K | 362.55% |
| Dec 31, 2010 | 1.17K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 428.57M |
| TELA Bio | 80.81M |
| Myomo | 41.21M |
| Cytosorbents | 37.20M |
| Baird Medical Investment Holdings | 22.54M |
| Lifeward | 20.92M |
| Pulsenmore | 12.55M |
| InspireMD | 10.85M |
NMTC News
- 21 days ago - NeuroOne Medical target adjusted to $8 from $1.60 at Ladenburg - TheFly
- 22 days ago - NeuroOne Medical Technologies Earnings Call Transcript: Q2 2026 - Transcripts
- 22 days ago - NeuroOne Medical Technologies Earnings release: Q2 2026 - Filings
- 22 days ago - NeuroOne Medical Technologies Quarterly report: Q2 2026 - Filings
- 7 weeks ago - NeuroOne Medical Technologies trading halted, news pending - TheFly
- 2 months ago - NeuroOne Medical Technologies Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference - Transcripts
- 2 months ago - NeuroOne Medical Technologies Transcript: Investor update - Transcripts
- 3 months ago - NeuroOne Medical Technologies Slides: Corporate presentation - Filings